Absfract: Cyclic sulfates 21-23 and sulfite 27 derived from glucofuranose lead to the 3,6_anhydrosugar 28 in excellent yields when treated with sodium sulfite or in basic media. When treated with sodium sulfite, the 3-deoxy derivative 24 fails to give the intramolecular cyclization which leads to the anhydrosugars. Instead it gives the disulfonate derivative 26. 28 was used as starting material to prepare bicyclonucleosides 43 and 46, which are analogues of the anti-HIV agents ddC and ddA. 0
INTRODUCTION
2',3'-Dideoxynucleosides 1-4 are some of the most active agents against HIV and other viruses.' Bicyclic analogues of nucleosides are conformationally restricted, so they have been widely used to synthesize antisense oligonucleotides. They facilitate the interaction with the complementary DNA or RNA, by stabilizing the pairing process, duplex formation.2 In fact, oligonucleotides containing bicyclic nucleosides have a greater affinity for complementary RNA or DNA. It has also been suggested that a C-3' exe conformation is predictive of anti-HIV activity.' Thus, it has been shown that a cyclopropane-fused dideoxycarbocyclic nucleoside, designed by V. E. Marquez et al. and structurally related to neplanocin-C, is forced to adopt a typical N-geometry.4 Bicyclic nucleoside analogues incorporating a fused methylene group (5),' oxirane (6)" or oxetane (7)' have been shown to inhibit HIV replication. Similar analogues of nucleosides containing a cyclopentyl (8-9)' were not active, and other related nucleosides (10-11) 9 have been prepared but no biological data reported. All these nucleosides have a hydroxymethyl group which is usually considered to be a requirement for antiviral activity." However, some nucleosides which have a secondary hydroxyl group, such as the bicyclic derivatives 12" and 16,12 which incorporate a hydroxylamino group, have shown antiviral activity. A related nucleoside designed by E. Kaes and co-workers," with the base appended at the C-5' hydroxyl group of the hexitol by a methylene linker, have also shown antiviral activity. Nucleoside 15 is an isonucleoside with a similar bicyclic backbone-l4 Figure 1 Several authors have used similar nucleosides such as 13"" and 14" to prepare oligonucleotides.
The bicyclic framework in compounds lo-15 has been synthesised from isosorbide (compounds 10, 11, 15) , by internal rearrangement of 3,5,6-Gorthoester glucose derivatives (compound 14) , from a 3-O-mesyl glucofuranose derivative (compound 12), or from cyclopentylderivatives (compound 13). Cyclic sulfites and sufates of vicinal dials have recently been shown to be useful intermediates in carbohydrate synthesis.16 Continuing our studies in cyclic sulfites and sulfates we describe in this paper a new easy route for the synthesis of 3,6-anhydro-1,2-G isopropilidene-a-D-glucofuranose starting from a sulfite and its transformation into 2',3'-dehydroxy bicyclic nucleosides (See Scheme 1) that can be considered as analogues of ddA and ddC with restricted conformational mobility. 
RESULTS AND DISCUSSION
The reaction of 5,6-cyclic sulfate sugar derivatives with sulfur,'6a.b,d selenium,'6a nitrogen," fluorine" and carbon'bc.'8 nucleophiles allow a regiospecific ring opening which generates a secondary O-sulfate salt or alcohol function on workup with dilute acid. Considering this behaviour and continuing our studies on the reactivity of cyclic sulfate sugars, it was expected that treating the .5,6-cyclic sulfates 21-24 with sodium sulfite would lead to the corresponding 6-sulfonic acid derivatives. However, this only happened in the case of the 3-deoxy derivative 24 when compound 26 was isolated in an 85% yield. For cyclic sulfates 21-23 the reaction product was characterised as the 3,6-anhydro sugar 25 which was isolated in a 7580% yield. Several anhydro sugars have been obtained by internal sugar ortho ester rearrangements in polar aprotic solvents under acid catalysis.19 A review of the literature showed that KS. Kim et al. obtained a similar result" in the reaction of cyclic sulfate sugars with phosphines. These 3,6-anhydro sugars form because of the remote participation of the oxygen atom present at C-3 via an oxonium ion intermediate. Similar cyclizations have been described in a variety of different substrates which have a leaving group present in the 6 position with respect to an oxygen atom of an ether or ester function.*' In order to demonstrate that this process is generalized, NaHCO, was used as a weak base and the reactions of 21-23 were performed in aqueous THF. Compound 25 was again the only reaction product isolated in similar yields (Scheme 2). Because the bicyclic structure 25 just described forms so easily, it was thought that this could be synthetically exploited to give access to bicyclonucleoside analogues of ddC and ddA. In this respect, the derivative 28 is the pivotal compound for the synthesis. Although it can be obtained by treating 25 with acid, its synthesis could be improved by using the cyclic sulfite 27 as the starting material and by reaction with NaOMe in methanol. In this way compound 28 was obtained in an overall yield of 80% from 17. This result shows that the synthetic strategy described is a straightforward and high yielding route for the synthesis of 3,6-anhydro sugars using inexpensive reagents (Scheme 3). Compound 28 was transformed into compounds 30 and 36 which were considered to be appropriate starting materials for N-glycosylation.
Initially we chose to protect the free hydroxyl group in 28 by reaction with benzyl bromide, since benzyl ether is stable in the basic conditions required for selective deprotection of 2-OAc and for substituting chlorine in 31. 6-Chloropurine was considered to be an appropiate base because it enables various substituents to be easily introduced at position 6. Thus, compound 28 was initially treated with benzyl bromide to give compound 29 which was hydrolyzed and subsequently reacted with acetic anhydride to obtain compound 30. 6-Chloropurine was glycosylated by reaction with 30 in the presence of BSA and with trimethylsilyl triflate as a promoter, to obtain nucleoside 31 in a 64% yield. Initially we attempted to transform 31 into the hypoxantine derivative by treating it with mercapto ethanol. This led to compound 32 in an 87% yield. 32 was deoxygenated with the Barton procedure (i. e. treatment with phenoxythiocarbonyl chloride and subsequently with tributyltin hydride) to obtain 33 with a moderate yield. However, all attempts to deprotect the benzyl group in 32 or in 33 under hydrogenolytic conditions (Pd-C, Pd(OH),-C, Ni-Raney) '* were unsuccessful even at 70 bar of pressure. In all cases, the starting material was recovered. Treatment with oxidants such as DDQ" or with Lewis acid? such as BCl, led to the deglycosylated compound. So, this approach was abandoned and the pivaloyl group was used as the protective group.
Following a similar scheme of synthesis, compound 28 was treated with pivaloyl chloride to give compound 34, which by subsequent hydrolysis and acetylation gave compound 36. Using a similar glycosylation procedure, Uracil and N6-Bz-Adenine were glycosylated with 36 to afford compounds 37 and 38, respectively, in an 80% yield in both cases. When the reaction was performed with cytosine under the same conditions, yields were very low. The use of acetylcytosine improved the yield, but various attempts to selectively deprotect the acetyl group were unsuccessful, because in all cases the acetamido group was also deprotected. Due to these negative results, we decided to synthesise the deoxycytidine from the uracil derivative 37.
37
Position 2 of 37 and 38 was deacetylated using a dilute solution of ammonia in methanol (Scheme 4). In these conditions, the acetoxy group reacts much faster than pivaloy and benzoyl groups. Compounds 39 and 40 were deoxygenated with the Barton procedure to lead to compounds 41 and 42 in good yields." Treatment of 41 in basic media led to the uridine nucleoside 44. The uracil derivative 41 was transformed into the cytosine derivative 46 with a well established protocol. It was treated with I-mesyl-3-nitro-1,2,4-triazole (MSNT) in the presence of diphenylphosphate to give compound 45, which by reaction with ammonia in methanol leads to the cytosine derivative 46.'" In the same way, compound 42 was deprotected by reaction with ammonia to give adenine derivative 43. As has been mentioned, the presence of a second ring fused to the furanoid decreases the conformational mobility of nucleosides. Bicyclonucleosides are usually found in a low-energy conformation, but there may be a lower proportion of other conformers. To find out whether 43 and 46 had a single conformation or whether there is a mixture of conformers in solution we decided to record an NMR 'H spectrum at different temperatures of I-(3',6'-anhydro-Dglucofuranosyl)-cytosine.
Throughout the experiment, which started at 40°C and was cooled to -78°C the appearance of the spectrum did not change. The signals were seen to broaden, perhaps because the viscosity of the solvent increased.
NOE experiments were done to obtain information about the furanose ring. Due to the similarities between the coupling constants of products 43 and 46 the experiments were done with compound 46. After H-6 had been irradiated it was found that the nitrogenated base was in a synlunti equilibrium. NOE effects obtained after the irradiation of H-l', H-3' and H-5' were consistent with a C-4'-exe conformation, possibly due to a gauche effect between the two endocyclic oxygens.
Figure 2. NOE experiments
The PSEUROT program was used to corroborate the information obtained with NOE experiments about the conformation of .NH, the sugar ring." Two N-conformers were found to be in equilibrium: P,= -70.5, v, = 34.9 and X, = 0.53 values were found for the first one that are in agreement with a 'T, conformation. Pz = 62.6 and v, = 85.9 values for the second one are consistent with a ,p conformation.
In conclusion, a new family of bicyclonucleosides analogues of ddC and ddA have been prepared from D-glucose using an intramolecular sulfate substitution as key step. The nucleoside analogues 43 and 46 were tested for their in vim inhibitory effects on the replication of HIV-l in CEM-SS and MT-4 cell systems. None of these compounds showed marked antiviral effects or detectable alteration of host-cell morphology at the highest concentration tested (100 yM). When evaluated in anti-HBV assays in HepG2 cells, none of the tested compounds showed any antiviral effect (up to a concentration of 100 pM) nor cytotoxicity (up to a concentration of 200 yM).
EXPERIMENTAL
General methods. All solvents were distilled before use. Thin layer chromatography (TLC) was performed using Alugram Sil G/UV_ Dtiren, and charring with H,SO,/EtOH 20:300. Column chromatography (CC) was performed on silica gel (Matrix Silica 60A, 40-60 pm SDS). Radial chromatography (RC) was performed on a 7924T Chromatotron Harrison Research apparatus, with silica 60 PF?,, Merck. Organic phases were dried over anhydrous magnesium sulfate or sodium sulfate. Concentrations were performed under reduced pressure. Melting points were recorded on a Tottoli Buchi 510 apparatus and are uncorrected. NMR spectra were recorded on a Varian Gemini-300 pulse Fourier transform spectrometer, with tetramethylsilane as internal standard when using CDCl, as solvent. Ultraviolet absorption spectra were recorded on a Diode Array HP 8452A spectrophotometer. Infrared spectra were recorded on a Hidac Prospect-IR Fourier transform spectrophotometer, with samples as neat liquids or nujol null between potassium bromide plates. Elemental analyses were performed with a Carlo Erba EA microanalyzer. Specific rotations were recorded on a Perkin-Elmer 241 MC apparatus, d=lO cm, and concentrations are given in mg/mL. Compounds 21-24 and 27 were synthesised according to the procedure described in the literature.'& 3,6-Anhydro-l,2-O-isopropylidene-5-O-sulfo-a-D-glucofuranose sodium salt (25). Procedure A: Sodium sulfite (1.1 mmol) was added to a solution of the cyclic sulfate 21-23 (1 mmol) in acetone-water (20 mL, 1:l). The solution was kept at rt for 16 h and then heated under reflux for 4 h. The solvent was evaporated to give a crude product that was purified by column chromatography (CHCl,-MeOH 5:1) giving 25 (7580%) as a solid. Procedure B: NaHCO, (1.1 mmol) was added to a solution of the cyclic sulfate 21-23 (1 mmol) in THFwater (25 mL, 4:l). The solution was heated under reflux for 4 h. The solvent was evaporated to give a crude product that was purified as described above giving 25 (75-80%) as white crystals: Mp 184-186 "C; [a] (2.5 mL, 20.3 mmol) and a catalytic amount of 4-dimethylaminopyridine (10 mg) were added to a solution of 28 (2.88 g, 14.3 mmol) in dry pyridine (15 mL). The mixture was kept at rt for 24 h, poured into ice-water (100 mL), and extracted with CH2Cl, (150 mL). The organic phase was washed with 5% HCl(2 x 150 mL), aq. NaHCO, (150 mL), and water (100 mL), and then dried and concentrated.
The crude product was purified by column chromatography (ether:hexane 1:l) to give 34 (4.0 g, 98%) as a solid: Mp 57-58 "C; [a] 
3,6-Anhydro-5O-pivaloyl-a$-D-glucofuranose (35).
A solution of 34 (3.9 g, 13.6 mmol) in 80% aq. AcOH (10 mL) was heated at 120-125 "C for 4 h. After this time, the starting material had completely disappeared from tic. After cooling, the reaction mixture was concentrated and coevaporated with toluene and the crude product was purified by column chromatography 
1,2-Di-0-acetyl-3,6-anhydro-5-O-pivaloyl-a,~-D-glucofuranose (36).
Compound 35 (2.7 g, 11 mmol) was acetylated overnight at rt with acetic anhydride (10 mL, 106 mmol) and pyridine (6 mL). The mixture was treated with an excess of methanol and evaporated with several portions of added methanol followed by toluene. 82.8, 81.4, 72.7, 69.1 (C2p, 3p, 5p, 6p), 78.9, 77.2, 71.6, 3a, 5a, 6a), 38.8 (Me, C), 27.05 (Me&Z), 20.9, 20.7, 20.4, 20.1 (MeCO) ; Anal. Cald. for C,,H,,O,: C, 54.54; H, 6.67. Found: C, 54.68; H, 6.66.
3,6-Anhydro-5-O-benzyl-l,2-O-isopropylidene-a-D-glucofuranose (29).
A suspension of 4.0 g of NaH (60% dispersed in mineral oil) in 39 mL of THF was added to a solution of 2.37 g (11. 7 mmol) of 28 in 47 mL of anhydrous THF. After stirring for 30 min at 0 "C, 4 mL (33.6 mmol) of BnBr was slowly added under argon. The reaction was controlled by TLC (EtOAcIHexane 1:3) and quenched by adding methanol after stirring for 5 h at rt. The reaction crude was purified by CC (EtOAc/Hexane 1:3) to give 25 (2.9 g, 84%) as a white solid, Mp. 86.6-90.8 "C. TLC (EtOAcIHexane 1:3): Rf=O.40. [a] ."+84 (c 5, CHCl, ) ; 'H NMR (CDCl,, 6 in ppm): 7.45 (m, 5H, H-Ar), 6.01 (d, lH, J,,,=3.5Hz, H-l), 4.94 (t, lH, J,,j=J,,=3.7Hz, H-4), 4.75,4.56 (q, 2H, AB system, J=11.8 Hz, PhCf-Z,), 4.58,4.47 (2d, 2H, H-2,3), 4.08-4.02 (ddd, lH, J,,=7.0Hz, J,,.=85Hz, H-5), 3.92-3.88 (dd, lH, J,,.=8.2Hz, H-6), 3.71-3.66 (m, lH, H-6'), 1.50, 1.33 (2s, 6H, Me,C); "'C NMR (CDCl, , 6 in ppm: 137.3, 128.4, 127.9 (C, H, ) , 112.3 (Me$ ) 107.1 (C-l), 85.5, 85.0, 80.6, 78.5, 72.4, 3, 4, 5, 6 and CH, Ph), 27.3, 26.6 (Me,C); Anal. Cald. for C,,H2,0,: C, 65.74; H, 6.85. Found: C, 65.77; H, 6.83.
1,2-Di-0-acetyl-3,6-anhydro-5-O-benzyl-oranose (30).
Ac,O (3 mL) and H,SO, (0.3 mL) were added to a solution of 2.85 g (9.79 mmol) of 29 in 30 mL of HOAc. The reaction mixture was stirred at rt until starting material disappeared from the TLC. After 5h it was quenched by adding a mixture of ice and NaHCO, 5%. After repeated extractions with CHCl, the resulting mixture of a and p anomers was purified by CC using Hexane/EtOAc 1:3 as eluent. This led to 30 (2.42g, 74%) as a foam; 'H NMR (CDCl,, 6 in ppm): 7.27-7.38 (m, 5H, H-Ar), 6.57 (d, lH, J,,?=4.5Hz, H-la), 6.23 (s, lH, H-lp), 5.16 (s, lH, H-2P), 5.14 (dd, lH, J,,=3.4Hz, H-2@, 4.91 (t, lH, J, , =J, , =3.4Hz, 2H, PhCH, ), lH, 4.48 (d. lH, J, , =11.5 Hz, PhCH, ), lH, Js, , =7.3Hz, Js, , .=9.0Hz, , 4.01-3.89 (m, 2H, H-6, H-6'), 2.10-2.00 (OAc); "C NMR (CDCl,, 6 in ppm): 169.2 (CO), 137.3 (C-Ar), 128.3, 127.9 (CH-Ar), 100.5, 96.0 (C-la, lB), 85.0, 84.3, 83.0, 81.1, 78.7, 77.7, 77.6, 77.1, 72.5, 72.1, 69.9, 68.6 (C_2a,3a,4a,5a,6a, C-2p,3p,4p,5&6p (1.30 eq/mol of sugar) was added to the stirred suspension and warmed to 70-80 "C. The catalyst SnCl, or TMSOTf, (1.30 eq/mol of sugar) was added slowly and the solution was stirred for 20-45 minutes approximately and controlled by TLC. The reaction was quenched with a NaHCO, saturated solution and CH,Cl,, and then washed with NaHCO,. For 38 it was quenched with a NaHCO, saturated solution and EtOAc and extracted with EtOAc. The combined organic phase was dried with Na,SO, and evaporated. The residue was purified by CC or RC.
6-Chloro-9-(2'-O-acetyl-3',6'-anhydro-5'-O-benzyl-~-D-glucofuranosyl)-purine (31).
When the general procedure was applied to carbohydrate 30 (260 mg, 0.77 mmol), 6-chloropurine (137 mg), ClC,H, (8.9 mL), BSA (0.25 mL), TMSOTf (0.18 mL), the reaction finished in 40 min. CC and RC (EtOAc/Hexane l:l, 3:2 and 2:l) gave 31 (219mg, 64%) as a white foam. When using SnCl,, a 1 :l mixture of N-7 and N-9 isomers was obtained. TLC (EtOAc/I-Iexane 3:2): Rf=0.25. [<xl, +56 (c 9, CHCl, ) . UV(MeOH): hmaX=264nm; 'H NMR (CDCl,, 6 in ppm): 8.75 (s, lH, H-2), 8.59 (s, lH, H-8), 7.28 -7.10 (m, 5H, H-Ar), 6.43 (d, lH, J,.,,.=1.7 Hz, H-l'), 5.72 (bd, lH, H-2'), 5.02 (t, lH, J,.,,.=J,.,s.=4.4 Hz, H-4'), 4.60 (dd, lH, J, .,*. =0.9 Hz, H-3'), 4.56 and 4.46 (2d, 2H, AB system, J=ll.SHz, PhCH,), 4.28-4.22 (m, lH, H-5') 3.99 -3.90 (m, 2H, H-6',6"), 2.15 (s, 3H, MeCO); "C NMR (CDCl, , 6 H, 5.80; N, 7.33; Found: C, 53.56; H, 5.82; N, 7. 31. [(x1, +84.2 (c 16.8, CHCl, ) . UV(CHC1,): h_=282nm; 'H NMR (300 MHz, CDCl,) 6 in ppm, 9.28 (s, lH, 8.78 (s, lH, 8.43 (s, lH, 8.04 (d, lH, J on" =7.2 Hz, 3H, 6.44 (d, IH, J, ., , .=1.5 Hz, 5.71 (bs, lH, 5.21 (ddd, lH, J, ., J.=3.7 Hz, J, ., b.=6.9 Hz, J, ., ..=5.4 Hz, 5.12 (dd, lH, J, ., j.=5.1 Hz, lH, 4.17 (dd, lH, J, .&O.2 Hz, H-6'), 4.03 (dd, lH, H-6"), 2.06 (s, 3H, MeCO), 1.01 (s, 9H, Me,C); 'C NMR (75.4 MHz, CDCl, ) 6 in ppm, 178.0, 169.3, 164.8 (CO), 85.7, 83.0, 80.9, 73.3, 3', 4', 5', 6'), 38.4 (Me, C), 26.6 (Me, (Z), 20.5 (M&O). Anal. calcd. for CZsH, , N, O, : C, 58.94; H, 5.30; N, 13.75. Found: C, 58.78; H, 5.29; N, 13 .77. . [a] , +160 (c 5.6, MeOH) . UV (MeOH): h_=246 nm; IR, 3258,3130,2950 IR, 3258,3130, , 1687 IR, 3258,3130, , 1586 IR, 3258,3130, , 1546 IR, 3258,3130, , 1204 IR, 3258,3130, , 1074 'H NMR (CD,OD, 6 in ppm): 8.36 (s, lH, H-2), 8.03 (s, lH, H-8), 7.25-7.23 (m, 5H, H-Ar), 6.20 (d, lH, J,.,z.=1.2 Hz, H-l'), 5.05 (t, lH, J,.,.=J,.,s.=4.5 Hz, H-4'), 4.80 (d, lH, H-2'), 4.64 (d, lH, J,,=11.4 Hz, H-7'), 4.49 (d, lH, H-7") 4.49 (dd, lH, J,,.,.--1.2 Hz, H-3'), 4.34-4.28 (m, lH, H-5'), 3.93 (dd, lH, J,.,.=6.6 Hz, J,.,..=9.6 Hz, H-6'), 3.78 (dd, lH, J,.,..=4.8 Hz, H-6"); "C NMR (CD,OD/CDCl, l:l, 6 in ppm): 146.2 (C-2), 140.1 (C-8), 129.0-128.6 (CH-Ar), 93.5 (C-l'), 89. 1, 85.2, 82.3, 79 .6 (C-2', C-3', C-4', C-5'), 73.2, 72.1 (C-6', C-7'). Anal. Calcd. for C, , H, , N, O, : C, 58.38%; H, 4.86%; N, 15.12%. Found: C, 58.21%; H, 4.87%; N, 15 .10%.
N6-Benzoyl
Selective deprotection of 0-acetyl groups of compounds 37 and 38. General method. The acetylated compound 37 or 38 was dissolved in MeOWNH, (lo-20% in NH,) and stirred at room temperature for 50 min -3 h. The reaction was controlled by TLC. After quenching the reaction by evaporation under reduced pressure, the residue was purified by CC or RC. [a] , i-177 (c 4, CHCl, ) . UV(MeOH): hmaX=270nm; IR, 3466, 3130,2980 IR, 3466, 3130, ,2885 IR, 3466, 3130, , 1700 IR, 3466, 3130, , 1693 IR, 3466, 3130, , 1622 IR, 3466, 3130, , 1468 IR, 3466, 3130, , 1413 IR, 3466, 3130, , 1393 IR, 3466, 3130, , 1260 , 1090 cm-'; 'H NMR (CDCl,, 6 in ppm): 10.28 (s, lH, H-3), 7.77 (d, lH, J,,=8.1 Hz, H-6), 5.86 (s, lH, H-l'), 5.71 (d, lH, H-5), 5.32-5.25 (m, lH, H-5'), 5.13 (dd, lH, J,.,,.=3.0, J,.,,.=5.1 Hz, H-4'), 4.51 (s,lH, H-2'), 4.41 (d,lH, H-3') 4.10 (dd, lH, J,.,s.=7.5 Hz, J,.,c..=10.5 Hz, H-6'), 3.90 (dd, lH, J,..,,.=3.9 Hz, H-6") 1.23 (s, 9H, Me&); "C NMR (CDCl,, 6 in ppm): 179.5, 162.0, 150.5 (CO), 139.7 (C-6), 101.7 (C-l'), 95.8 (C-5), 87.6, 84.1, 79.3, 74.5 (C-2', 3', 4', 5') , 71.7 (C-6'), 38.5 (Me&'), 27.0 (Me,C). Anal. calcd. from C, , H, , N, O, : 52.94; H, 5.88; N, 8.23. Found: C, 53.04; H, 5.90; N. 8.20 .
1-(3',6'-Anhydro-5'-O-pivaloyl-P-D-glucofuranosyl)-uracil (39

N6-Benzoyl-9-(3',6'-anhydro-5'-O-pivaloyl-P-D-glucofuranosyl)-adenine (40).
When the general method was applied to compound 38 (575 mg, 1.13 mmol), 20 mL of MeOH/NH, (10% in NH,), RC (mixtures of CH,ClmeOH) gave of 40 (446 mg, 84%) as a white foam. TLC (CH,Cl,/MeOH 2O:l): Rf=0.56. [a] "'"+1 16 (c 10.4, CHCl, ) . UV(MeOH): hmaX=280nm; 'H NMR (CDCl,, 6 in ppm): 9.37 (s, lH, H-6), 8.60 (s, lH, H-2), 8.38 (s, lH, H-8), 7.94 (d, 2H, Jon0=7.2 Hz, H-Ar), 7.58-7.43 (m, 3H, H-Ar), 6.26 (d, lH, J,.,,.=2.1 Hz, H-l'), 6.20 (s, lH, OH), 5.19-5.07 (m, 2H, H-4', H-5'), 4.93 (bs, lH, H-2'), 4.59 (d, lH, J,.,,.=3.6 Hz, H-3'), 4.09 (dd, lH, 5,.,,.=6.6, 5,.,,..=10.2 Hz, H-6'), 3.90 (dd, lH, J,..,s.=5.4 Hz, H-6"), 1.08 (s, 9H, (CH,),); "C RMN (CDCl,, 6 in ppm): 178.1, 165.0 (CO) 152.5 (C-2), 141.7 (C-8), 133.3-127.9 (CH-Ar), 92.7 (C-l'), 87.9, 82.3, 79.6, 73.4, 70.1 (C-2',3',4',5',6') , 38.5 (Me,C'), 26.8 (Me,C). Anal. calcd. from C,,H,,N,O,: C; 59. 10; H, 5.35; N, 14.99. Found: C, 59.25; H, 5.36; N, 14.95 .
Synthesis of 2'-deoxy-derivatives 33, 41 and 42 by reductive deoxygenation. Genera procedure.
A. Formation of 2'-O-(phenoxythiocarbonyl)-derivatives. DMAP (0.5 eq/mol) ant PhOCSCl (2 eq/mol) were added under argon to a stirred solution of 32, 39 or 40 in dq CH,CN or Cl&H, (10 mL of solvent/l mmol of nucleoside). The mixture was stirred fo 40 min4 h. The reaction mixture was evaporated to dryness and the resultant residue wa partitioned with EtOAc/H,O and washed with HOAc 1N and NaCl solution. The organic layer was dried with Na,SO, and evaporated. The resultant foam was purified by CC o used without purification in the deoxygenation reaction. B. Deoxygenation reaction. AIBN (35 mg/mmol) and n-Bu,SnH (2.3 eq/mmol) were adder to a stirred solution of the thiocarbonate in dry toluene (previously deoxygenated witl argon). The reaction was carried out in refluxing toluene and controlled by TLC. The solvent was evaporated and the residue purified by CC or RC. 84.7, 82.6, 78 .6 (C-3',4',5'), 72.2 71.9 (C-6', PhCH,), 36.7 (C-2'). Anal. calcd. from C, , H, , N, O, : C, 61.02; H, 5.07; N, 15.82 Found: C, 61.10; H, 5.08; N, 15. 86.
1-(3',6'-Anhidro-2'-deoxy-5'-O-pivaloyl-~-D-glucofuranosyl)-uracil
(41). The genera procedure for the formation of 2'-0-(phenoxythiocarbonyl)-derivatives was applied to 39 (60( mg, 1.76 mmol), CH,CN (17.6 mL), PhOCSCl (0.5 mL) and DMAP (108 mg). To tht resultant foam (used without purification) the deoxygenation general method was applied toluene (14 mL), AIBN (61 mg) and n-Bu,SnH (1 mL). The CC (mixtures of CH,ClJMeOH: gave 41 (460 mg, 80%) as white crystals, Mp 199-200 "C (from CHCl,/Pentane); [a] , +159 (( 4, CHCl, ) . TLC (CH$I,/MeOH 25:l): Rf=0.25. UV(MeOH): h,,_=262nm; IR, 3151, 3110 3021,2975 IR, 3151, 3110 3021, , 1730 IR, 3151, 3110 3021, , 1727 IR, 3151, 3110 3021, , 1706 IR, 3151, 3110 3021, , 1682 IR, 3151, 3110 3021, , 1470 IR, 3151, 3110 3021, , 1268 IR, 3151, 3110 3021, , 1096 'H NMR (CDCI,, 6 in ppm); 9.9: (s, 1J-L H-3), 7.83 (d, lH, J,,=8.4 Hz, H-6), 6.32 (dd, lH, J,.,,..=8.1, J ,.,*. =3.0 Hz, H-l'), 5.78 (d lH, l-J-5) 5.20-5.18 (m, lH, H-5'), 4.79 (dd, J,.,X.=3.6, J,. ,*.. =5.7 Hz, lH, H-4'), 4.59-4.57 (m 1J-k H-3'), 4.11-4.01 (m, 2H, H-6', H-6"), 2.72 (ddd, lH, J,..,.=l5.6, J,..,j.=5.3 Hz, H-2"), 2.31 (dd, 1l-L H-2'), 1.19 (s, 9H, Me, C) ; "'C NMR (CDCl, , 6 in ppm); 179.0, 163.9, 150.7 (CO) 140.6 (C-6), 102.1 (C-l'), 87.2 (C-5), 83.7, 83.0, 74.1, 71.8 (C-3',4',5',6 '), 38.1 (C-2'), 38.: (Me,0 269(Me,C). Anal. calcd. from C, , H, , N, O, : C, 55.56; H, 5.17; N, 8.64. Found: C 55.54; H, 5.18; N, 8.64. 
